Ronald S Karo, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1300 Massachusetts Ave, Troy, NY 12180 Phone: 518-268-5590 |
Harold Haber, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1300 Massachusetts Ave, Troy, NY 12180 Phone: 518-268-5590 |
Britton Limes, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1300 Massachusetts Ave, Troy, NY 12180 Phone: 518-268-5590 |
Dr. Ajit K Khanuja, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1444 Massachusetts Ave, Suite 308, Troy, NY 12180 Phone: 518-272-1212 Fax: 518-272-9228 |
Dr. Kakulavaram Venkat Reddy, MD Radiology - Therapeutic Radiology Medicare: Not Enrolled in Medicare Practice Location: 2215 Burdett Ave, Samaritian Hospital Cancer Care Center, Troy, NY 12180 Phone: 518-271-3220 Fax: 518-271-3459 |
Jay K Salwen, Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1300 Massachusetts Ave, Troy, NY 12180 Phone: 518-268-5590 |
Donald Killam, Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: Samaritan Hospital, 2215 Burdett Ave-radiology, Troy, NY 12180 Phone: 518-271-3417 |
News Archive
A new study by Craig Thiessen, M.D., Director of Radiology for West Houston Radiology L.L.P. and North Cypress Medical Center in Houston, presented this week at the National Consortium of Breast Centers Annual Meeting, found the improved photon sensitivity of new detector technologies such as PSPMTs and CZT should be capable of reducing the radiation dose patient receive from BSGI/MBI studies by 75%.
Many post-bariatric surgery patients experience an extreme loss in skin elasticity that leads them to have body contouring procedures, which greatly differ from contouring procedures performed on normal weight patients.
PHNS Inc. announced that it has been engaged by NorthBay Healthcare (NorthBay), Fairfield, California, to begin the process of assessing its readiness for its migration from ICD-9 to ICD-10. PHNS was awarded this Phase 1 of a multi-phase project for NorthBay.
Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.
› Verified 9 days ago